10 results · 6ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Sekisui Spectrolyse PAI-1, In-Vitro Diagnostic for Quantitative determination of Plasminogen Activator Inhibitor Type- 1 (PAI-1) activity in human plasma. Catalog Number: 101201 For the determination of Plasminogen Activator Inhibitor Type 1 (PAI-1) activity in human plasma. The test is for in Citro diagnostic use.

FDA Enforcement
Class II ·Terminated·Sekisui Diagnostics Llc·September 26, 2012

Sekisui Diagnostics, Spectrolyse PAI-1 In-Vitro Diagnostic Use for the quantitative determination of Plasminogen Activator Inhibitor Type 1 in human plasma. Catalog # 101201. Spectrolyse PAI-1 is intended for the quantitative determination of Plasminogen Activator Inhibitor Type-1 (PAI-1) activity in human plasma. The test is for in vitro diagnostic use.

FDA Enforcement
Class II ·Terminated·Sekisui Diagnostics Llc·December 12, 2012

lmpella CP with Smart Assist, Model Number: 0048-0003. Left heart support blood pump, for Use During Cardiogenic Shock and High-Risk PCI

FDA Enforcement
Class II ·Terminated·Abiomed, Inc.·November 13, 2019

Signature Ceramic Femoral Head. Model Number: 111-152-621. The Signature ceramic femoral heads are manufactured by Ceramtec from 72-75% Al2O3+24-26% Z3O3 (Biolox Delta). The heads connect via a 12/14 taper to the stem trunnion, and articulates against the crosslinked UHMWPE liner within the Logical Acetabular Cups. Product Usage: Components of the Signature Orthopaedics hip replacement range are intended to replace a hip joint where bone stock is sufficient to support the implant. When a surgeon has selected prosthetic replacement as the preferred treatment, the devices are indicated for: ¿ Non-inflammatory degenerative joint disease including osteoarthritis or avascular necrosis ¿ Inflammatory joint disease including rheumatoid arthritis ¿ Correction of functional deformity including congenital hip dysplasia ¿ Traumatic injury involving the hip joint including traumatic arthritis or femoral head or neck fracture ¿ Failed previous hip surgery including internal fixation or joint fusion, reconstruction, hemiarthroplasty, surface replacement, or total replacement

FDA Enforcement
Class II ·Terminated·Signature Orthopedics Pty Limited·March 14, 2018

SOUTHERN IMPLANTS REF IBR12d-13, Implant, Ext. Hex, tapered 12o Co-Axis(TM) intended for surgical placement in the upper or lower jaw to provide a means for prosthetic attachment of crowns, bridges or overdentures utilizing delayed or immediate loading.

FDA Enforcement
Class II ·Terminated·Southern Implants, (Pty.) Ltd.·April 25, 2018

Genius Knee Cemented Tibial Component Product Usage: Knee replacement component

FDA Enforcement
Class II ·Terminated·Signature Orthopedics Pty Limited·February 20, 2019

Genius Knee Cemented CR Femoral Component Product Usage: Knee replacement component

FDA Enforcement
Class II ·Terminated·Signature Orthopedics Pty Limited·February 20, 2019

Cocoon Convective Warming System, Product Code: CWS4000 (110V).

FDA Enforcement
Class II ·Terminated·Care Essentials Pty., Ltd.·February 12, 2020

Cocoon Convective Warming System, Product Code: CWS5000 (110V).

FDA Enforcement
Class II ·Terminated·Care Essentials Pty., Ltd.·February 12, 2020

Logical cup liner - Product Usage: intended to replace a hip joint where bone stock is sufficient to support the implant.

FDA Enforcement
Class II ·Terminated·Signature Orthopedics Pty Limited·June 9, 2021